As diabetes care continues to be a significant focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy evolution in incretin mimetic medications. While all https://doctorbookmark.com/story22215606/retatrutid-vs-tirzepatid-vs-semaglutide-a-direct-comparison